Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Jan 30, 2026 → Apr 30, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. | 0 | 596,585 | 596,585 | 1.21% | $14.94M |
| BIONTECH SE ADR | 0 | 126,929 | 126,929 | 1.07% | $13.13M |
| LILLY ELI and CO | 0 | 12,571 | 12,571 | 0.95% | $11.75M |
| GENERATE BIOMEDI | 0 | 503,531 | 503,531 | 0.52% | $6.36M |
| Goldman Sachs Financial Square Treasury Obligations Fund | 0 | 1,581,573 | 1,581,573 | 0.13% | $1.58M |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| AMGEN INC | 45,055 | 0 | -45,055 | 0.00% | -$15.40M |
| INCYTE CORP | 135,992 | 0 | -135,992 | 0.00% | -$13.61M |
| VERTEX PHARMACEUTICALS INC | 25,948 | 0 | -25,948 | 0.00% | -$12.19M |
| CARIS LIFE SCIENCES INC | 407,334 | 0 | -407,334 | 0.00% | -$9.43M |
| VEEVA SYSTEMS-A | 40,948 | 0 | -40,948 | 0.00% | -$8.35M |
| STANDARD BIOTOOLS INC | 3,063,591 | 0 | -3,063,591 | 0.00% | -$4.29M |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 2,675,731 | 0 | -2,675,731 | 0.00% | -$2.68M |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| TEMPUS AI INC-A | 1,755,350 | 2,098,455 | 343,105 | 9.45% | $11.42M |
| CRISPR THERAPEUTICS AG | 2,034,541 | 2,103,707 | 69,166 | 8.94% | $8.46M |
| BEAM THERAPEUTICS INC | 2,209,480 | 2,212,153 | 2,673 | 5.44% | $6.07M |
| NATERA INC | 236,502 | 243,718 | 7,216 | 4.08% | -$4.42M |
| INTELLIA THERAPEUTICS INC | 2,995,166 | 3,498,399 | 503,233 | 3.83% | $7.77M |
| RECURSION PHARMACEUTICALS INC | 12,153,128 | 12,549,240 | 396,112 | 3.52% | -$7.50M |
| COMPASS Pathways PLC, ADR | 2,145,054 | 3,316,076 | 1,171,022 | 2.44% | $15.69M |
| NURIX THERAPEUTICS INC | 1,592,110 | 1,723,734 | 131,624 | 2.34% | $2.48M |
| GENEDX HOLDINGS CORP-A | 205,719 | 401,292 | 195,573 | 2.05% | $5.43M |
| ARCTURUS THERAPEUTICS HOLDINGS INC | 2,613,794 | 2,809,043 | 195,249 | 1.97% | $4.69M |
| ATAIBECKLEY INC | 3,299,659 | 4,382,604 | 1,082,945 | 1.48% | $5.82M |
| CERUS CORP | 6,691,243 | 7,450,534 | 759,291 | 1.23% | -$466.01K |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| TWIST BIOSCIENCE CORP | 2,229,125 | 1,900,539 | -328,586 | 9.02% | $19.54M |
| 10X GENOMICS INC | 3,288,358 | 3,232,541 | -55,817 | 5.78% | $4.85M |
| ABSCI CORP | 12,019,802 | 11,876,202 | -143,600 | 4.79% | $23.14M |
| ILLUMINA INC | 397,493 | 392,835 | -4,658 | 4.04% | -$7.77M |
| PERSONALIS INC | 8,329,028 | 8,017,242 | -311,786 | 3.59% | -$33.79M |
| GUARDANT HEALTH INC | 667,442 | 496,000 | -171,442 | 3.51% | -$32.92M |
| CAREDX INC | 2,126,762 | 2,009,757 | -117,005 | 3.39% | -$1.88M |
| VERACYTE INC | 1,097,405 | 999,975 | -97,430 | 2.67% | -$8.87M |
| ADAPTIVE BIOTECHNOLOGIES CORP | 2,149,231 | 2,123,561 | -25,670 | 2.43% | -$9.82M |
| SCHRODINGER INC | 2,118,509 | 2,093,199 | -25,310 | 2.03% | -$4.56M |
| BUTTERFLY NETWORK INC A | 6,229,192 | 4,889,029 | -1,340,163 | 1.90% | -$1.25M |
| IONIS PHARMACEUTICALS INC | 402,154 | 288,230 | -113,924 | 1.75% | -$11.70M |
| PRIME MEDICINE INC | 4,985,424 | 4,925,864 | -59,560 | 1.42% | -$1.53M |
| PACIFIC BIOSCIENES OF CALI INC | 11,140,437 | 10,964,895 | -175,542 | 1.41% | -$7.74M |
| 908 DEVICES INC | 1,976,162 | 1,952,552 | -23,610 | 1.08% | $866.35K |
| QUANTUM-SI INC | 7,012,113 | 6,928,343 | -83,770 | 0.55% | -$1.13M |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.